USPTO serial 79213675
OXFORD NANOPORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CAPSHAW, DANIEL
- Law office
- TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with OXFORD NANOPORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for scientific and industrial use; chemical diagnostic reagents for scientific use; reagents for use in automated test systems for scientific and industrial use; reagents for analytical tests for scientific and industrial use; reagents for industrial scientific and industrial use; reagents for use in science; reagents for scientific and industrial laboratory use; reagents for use in molecular biology, biotechnology, microbiology, and bacteriology; reagents for nucleic acid amplification; reagents for use in forensic analysis; reagents for blood grouping for scientific and industrial use; reagents for use in environmental testing and environmental analysis; reagents for testing water and other liquids for scientific and industrial use; reagents for testing aqueous solutions for scientific and industrial use; deoxyribonucleic acid, single stranded and double stranded deoxyribonucleic acid for scientific and industrial use; ribonucleic acid for scientific and industrial use; peptide nucleic acids for scientific and industrial use; locked nucleic acids for scientific and industrial use; nucleic acids for scientific and industrial use; oligonucleotides for scientific and industrial use; oligosaccharides for scientific and industrial use; proteins for scientific and industrial use; peptides for scientific and industrial use; chemicals, enzymes and reagents for use in genome, dna, rna and nucleic acid synthesis for scientific and industrial use; endonucleases, polymerases, ligases, glycosylases for scientific and industrial use; nucleotides, pyrimidines, purines for scientific and industrial use; amino acids for scientific and industrial use; saccharides for scientific and industrial use; reagents for biological processing for scientific and industrial use; reagents for use in nucleic acid characterization and nucleic acid sequencing for scientific and industrial use; reagents for protein identification and analysis for scientific and industrial use; chemicals for use in tests to detect diseases in plant life for scientific and industrial use; reagents for formation of amphipathic membranes for scientific and industrial use; chemical buffer solutions for use in chemistry; aqueous solvents for scientific and research use; non-aqueous solvents for scientific and research use; isopropanol for scientific and research use; ethanol for scientific and research use; phenol for scientific and research use; non-aqueous media in the nature of solid or liquid non-aqueous solutions for scientific or research use; surfactants for scientific and research use; silicone oils for scientific and research use; silicone fluids for scientific and research use; enzymes for scientific and research use; lytic enzymes including lysozyme, lyticase and cellulose for scientific and research use; proteases for scientific and research use; nucleases, including RNase, DNase and restriction enzymes for scientific and research use; chaotropes, including guanidine-HCl and guanidinium thiocyanate for scientific and research use; detergents for industrial and scientific use; proteins for use in analytical tests for scientific and research use; magnetic and non-magnetic microspheres made from synthetic materials including rubber, plastics or silicone, namely, beads for use in medical and scientific research; nucleic acid amplification reagents for medical research use; reagents for medical and veterinary research | ACTIVE | — |
| 005 | Reagents for use in automated test systems for veterinary or medical use; reagents for use in blood grouping for veterinary or medical use; reagents for medical and veterinary diagnosis; reagents for laboratory tests for medical or veterinary diagnostic purposes; nucleic acid amplification reagents for veterinary and medical use; reagents for immunoassay analysers, namely, for use in medical and veterinary diagnosis; reagents for testing aqueous solutions for use in medical and veterinary diagnosis; reagents for testing for susceptibility to allergies for use in medical and veterinary diagnosis; reagents for use in biological processing for use in medical and veterinary diagnosis; reagents for use in nucleic acid characterization and nucleic acid sequencing for use in medical and veterinary diagnosis; reagents for protein identification and analysis for use in medical and veterinary diagnosis; reagents for formation of amphipathic membranes for use in medical and veterinary diagnosis; blood substitute in the form of buffer solutions for medical and veterinary use; aqueous solvents for use in medical and veterinary diagnosis; non-aqueous solvents for use in medical and veterinary diagnosis; non-aqueous media in the nature of solid or liquid non-aqueous solutions for use in tests for medical and veterinary diagnostic purposes; surfactants for use in medical and veterinary diagnosis; silicone oils for use in medical and veterinary diagnosis; enzymes for use in medical and veterinary diagnosis; proteins for use in tests for medical or veterinary diagnostic purposes; magnetic and non-magnetic microspheres made from synthetic materials including rubber, plastics or silicone, namely, beads for medical or veterinary diagnostic purposes | ACTIVE | — |
| 035 | Analysis and evaluation of marketing, business and commercial data; provision of reports relating to the aforesaid; business information services; business consulting services; retail store services in the field of computer software used for scientific research and scientific testing purposes; the bringing together for the benefit of others, of third party scientific data analysis and data streaming services enabling customers to conveniently view and purchase those services; retail store services in the field of electronic sensing and measuring equipment, apparatus and instruments for scientific testing and research purposes; retail store services of in the field of sequencing equipment, apparatus and instruments for scientific testing and research purposes; retail store services in the field of data processing equipment, apparatus and instruments; retail store services in the field of scientific equipment, apparatus and instruments for scientific testing and research purposes; retail store services in the field of surgical, medical and veterinary equipment, apparatus and instruments; retail store services in the field of reagents, buffer solutions, solvents, surfactants, oils and other media for scientific, medical or veterinary purposes; retail store services in the field of chemicals and enzymes for scientific testing and research purposes; retail store services in the field of chemicals and enzymes for scientific, medical or veterinary purposes; retail store services in the field of deoxyribonucleic acid, single stranded and double stranded deoxyribonucleic acid, ribonucleic acid, peptide nucleic acids, locked nucleic acids, nucleic acids, oligonucleotides, oligosaccharides, proteins and peptides for scientific testing and research purposes; retail store services in the field of goods for use in a laboratory; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford Nanopore Technologies Limited
- Other trademarks owned by Oxford Nanopore Technologies PLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named OXFORD NANOPORE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 6, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 23, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 4, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 27, 2021 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 8, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 8, 2020 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 8, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 25, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 15, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 27, 2019 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 25, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 9, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 9, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 27, 2018 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 27, 2018 | ALIE | ASSIGNED TO LIE | — |
| Sep 27, 2018 | ALIE | ASSIGNED TO LIE | — |
| Mar 8, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 8, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 8, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 17, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 16, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 16, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 16, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 16, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 1, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 16, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 16, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 15, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 14, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 7, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 3, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |